The Closed Loop: Why Intratumoral ClO₂ May Be a Genuine Answer for Glioblastoma

Since filing for FDA Orphan Drug Designation for glioblastoma on April 8, we have steadily added to the evidence base behind the intratumoral ClO₂ ablation system — more veterinary tumor cases, and a closer look at how fast and how completely the reaction self-limits, most recently in whole blood.